48 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
. “Simultaneously, the company is building a community of genetic specialists, health care providers, caregivers and patients to better understand these disorders
8-K
EX-99.2
RYTM
Rhythm Pharmaceuticals Inc.
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
Launched in 2019 to educate health care providers, develop management strategies and build a peer-to-peer network 20 GOLD Academy faculty 20500 programs … completed or in process Health care providers have or are expected to participate 41 RESEARCH & DEVELOPMENT UPDATE SEPTEMBER 2019
Patient Finding
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
8 Mar 19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:04pm
of obesity due to impairments of the melanocortin-4 receptor (MC4R) pathway and building an integrated community of patients, caregivers, health care providers
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
-modifying therapeutic option.
“In collaboration with partners, patients and health care providers, Rhythm is advancing toward our goal of changing
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
advocacy groups on these conditions and the potential benefits of genetic sequencing, we are building a new community of patients, families and health … care providers focused on rare genetic disorders of obesity in both the United States and Europe.”
Second Quarter and Recent Business Highlights
8-K
EX-99.1
1y8mlpkm0auq
2 Nov 21
Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
qvzea
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am